Drug Trial Radar · NCT00758641
Platelet Rich Plasma to Treat Plantar Fasciitis
Last checked: Nov 21, 2026Latest source record: Mar 14, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
115
Actual
Start
Sep 2009
Primary completion
Jan 2016
Study completion Jan 2016
Sponsor
- Lead sponsor
- Zimmer BiometIndustry
- Sponsor type
- Industry
- Collaborators
- Elisabeth-TweeSteden Ziekenhuis; Diaconessenhuis Leiden Netherlands; Biomet Nederland BV
- First posted
- Sep 25, 2008
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Rationale: The standard treatment of chronic plantar fasciitis is corticosteroid injections. Corticosteroid injection give temporarily pain reduction, but no healing. Blood platelets initiate the natural healing rate. GPS ® gives an eightfold concentrate platelets of patients own blood. Injection of these platelets in the tendon might induce a healing rate. Objective: To compare the efficacy of autologous platelet concentrate injections with corticosteroid injection in patients suffering from plantar fasciitis with respect to pain and function.
Conditions
- Plantar Fasciitis
Interventions
L-PRP InjectionDevice
L-PRP produced with Biomet Recover L-PRP Platelet Separation Kit
Corticosteroid InjectionDrug
kenacort 40 mg/ml triamcinolon acetonide
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of successfully treated patientsTime frame: 6 months
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Haga ziekenhuis
DenHaag, Netherlands
Albert Schweitzer Ziekenhuis
Dordrecht, Netherlands
Diaconessehuis
Leiden, Netherlands
Academisch Ziekenhuis Maastricht
Maastricht, Netherlands
St Elisabeth Hospital
Tilburg, Netherlands
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.